Mycoplasma amphoriforme, M. genetalium, M. hominus, M. incognitus, M. pneumoniae. They all lack cell walls and are not gram stainable.
Person to person spread, M. pneumoniae is spread by coughing; rates go up when it is humid (PubMed).
Up to 25% of vectors, I mean young children, can be asymptomatic carriers. Since asymptomatic carriage is common, it makes false positive tests likely (PubMed).
M. pneumoniae: most have a URI, some go on to pneumonia with the CXR looks worse than the patient. Cold agglutinins, hemolytic anemia, bullous myringitis, encephalitis, myocarditis and pericarditis, erythema nodosum, urticaria, Stevens-Johnson, and polyarthralgias are part of this endlessly curious disease. Maybe methemoglobinemia (PubMed)
The neurologic manifestations may be due to cross reacting antibodies rather than direct CNS invasion (PubMed).
A new Mycoplasma (Hemoplasma) can cause a severe hemolytic anemia with fever (PubMed).
Mycoplasma amphoriforme causes pneumonia, including chronic/relapsing pneumonia in patients with primary antibody deficiency (PubMed).
M. hominus also has caused wound infections from tissue grafts from amniotic tissue (PubMed). Blech.
And there are outbreaks due to organ transplantation (PubMed).
Macrolides (although resistance is increasing espcially in Asia) OR doxycycline. The quinolones are also active. As of 2012, 8.2% are resistant to macolides (PubMed), although depending on the population, up to 66% of Mycoplasma pneumoniae can be macrolide resistant.
One meta-analysis suggests 5 days of azithromycin is better than a single 1 gm dose (PubMed).
Despite resistance, no difference in outcomes no matter which antibiotic is given to hospitalized patients with pneumonia; likely as it is a self limited disease (PubMed).
Mycoplasma genitalium may be better treated with 1 gram of azithromycin rather than doxycycline (PubMed, PubMed) but moxifloxacin is the only drug always effective (PubMed). 10% are resistant and resistance is increasing to quinolones and macrolides (PubMed). Other studies have found macrolide resistance in 38% of the M. genitalium patients, with 43% resistance in patients tested at sexually transmitted disease clinics (PubMed).
Resistance to macrolides can be as high at 69% in some series and is associated with a prolonged fever.